/BIB
BIB Stock - ProShares Ultra Nasdaq Biotechnology
Financial Services|Asset ManagementNASDAQ
$80.83+4.69%
+$3.62 (+4.69%) • Dec 19
71
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.BUY
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.98
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.62
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $88.91
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for BIB
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$80.02 – $81.64
TARGET (TP)$92.95
STOP LOSS$74.36
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Key Metrics
Market CapN/A
P/E RatioN/A
Beta1.46
52W High$84.06
52W Low$33.78
Avg VolumeN/A
Income Statement (Fiscal Year)
Loading financial data...
Company Overview
The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the fund's investment objective. The index is a modified capitalization weighted index that includes securities of Nasdaq listed companies that are classified as either biotechnology or pharmaceutical. The fund is non-diversified.
Loading analyst ratings...
Earnings History & Surprises
BIBLoading earnings data...
Latest News
Loading news...
Frequently Asked Questions about BIB
What is BIB's current stock price?
ProShares Ultra Nasdaq Biotechnology (BIB) is currently trading at $80.83 per share. The stock has moved +4.69% today.
What is the analyst price target for BIB?
No analyst price targets are currently available for this stock.
What sector is ProShares Ultra Nasdaq Biotechnology in?
ProShares Ultra Nasdaq Biotechnology operates in the Financial Services sector, specifically within the Asset Management industry. The company is traded on the NASDAQ exchange.
What is BIB's market cap?
ProShares Ultra Nasdaq Biotechnology has a market capitalization of $0.07 billion, making it a small-cap company.
Does BIB pay dividends?
No, ProShares Ultra Nasdaq Biotechnology does not currently pay a dividend to shareholders.
Similar Stocks
Financial Services SectorBKSE
BNY Mellon US Small Cap Core Equity ETF
$114.75
Mkt Cap: $0.1B
CAMX
Cambiar Aggressive Value ETF
$32.13
Mkt Cap: $0.1B
DIVL
Madison Dividend Value ETF
$23.00
Mkt Cap: $0.1B
GOP
Unusual Whales Subversive Republican Trading ETF
$36.75
Mkt Cap: $0.1B
ITDC
iShares LifePath Target Date 2035 ETF
$34.55
Mkt Cap: $0.1B
NACP
Impact Shares NAACP Minority Empowerment ETF
$49.65
Mkt Cap: $0.1B
RSEE
Rareview Systematic Equity ETF
$34.09
Mkt Cap: $0.1B
SNTH
MRP SynthEquity ETF
$30.77
Mkt Cap: $0.1B
TRND
Pacer Trendpilot Fund of Funds ETF
$34.42
Mkt Cap: $0.1B
URE
ProShares Ultra Real Estate
$58.47
Mkt Cap: $0.1B
Explore stocks similar to BIB for comparison